RVU120 (SEL120) in Patients with Relapse/Refractory Metastatic or Advanced Solid Tumors
Clinical trial NCT05052255 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05052255
- Sponsor
- Ryvu Therapeutics SA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2025-05-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.